Trials / Completed
CompletedNCT01146340
Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer
Phase I/II Study of Dose-Escalated Hypofractionated Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sunnybrook Health Sciences Centre · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of a short course of radiotherapy (40 Gy / 5 fractions / 29 days) for the treatment of low- and intermediate-risk prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Hypofractionated radiotherapy | 40 Gy / 5 fractions / 29 days |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2010-06-17
- Last updated
- 2019-10-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01146340. Inclusion in this directory is not an endorsement.